The Food and Drug Administration announced Monday it had approved a new kind of immunization to protect babies from RSV, or respiratory syncytial virus. The drug, nirsevimab, is one of two new options doctors hope could soon prevent the leading cause of hospitalization facing American infants. ...
[2] fda.gov/drugs/new-drugs [3] go.drugbank.com/ [4] Mullard A. FDA approves first-in-class AKT inhibitor. Nat Rev Drug Discov. 2024;23(1):9. doi:10.1038/d41573-023-00202-w [5] Kingwell K. γ-secretase inhibitor notches first approval. Nat Rev Drug Discov. 2024;23(1):9. ...
The FDA has approved Attruby, a new oral treatment that helps reduce heart-related deaths and hospital visits among adults with transthyretin amyloidcardiomyopathy,or ATTR-CM. ATTR-CM is a rare but serious long-term heart condition that may be inherited or related to aging. It is caused by a...
According to the report, the FDA has approved the use of the antimicrobial florfenicol in the swine feed to control respiratory tract disease. The category of the VFD drugs was created by the Animal Drug Availability Act of 1996.EBSCO_AspJournal of the American Veterinary Medical Association...
WASHINGTON, March 6 (Xinhua) -- TheUnited StatesFood and Drug Administration (FDA) approved on Tuesday a new type of antiretroviral medication for adult patients living with HIV who have tried multiple HIV medications in the past and whose HIV infections cannot be successfully treated with other ...
36.https://www.drugs.com/newdrugs/fda-approves-penbraya-meningococcal-groups-b-c-w-y-vaccine-prevention-five-most-common-serogroups-6120.html 37.https://www.fda.gov/media/175227/download?attachment 38.https://www.fda.gov/media/174318/download?attac...
Her cancer began shrinking almost immediately. "I feel as normal as I did before I had cancer," Warren told the Times. "There's a lot of hope with this drug."
The US Food and Drug Administration has approved the use of the drug tucatinib, or Tukysa, in combination with chemotherapy, for the treatment of adults with advanced forms of HER2-positive breast c…
SILVER SPRING, Md.,July 17, 2023/PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Beyfortus (nirsevimab-alip) for the prevention of Respiratory Syncytial Virus (RSV) lower respiratory tract disease in neonates and infants born during or entering their first RSV...
[1]https://www.fiercepharma.com/special-reports/2023-drug-approvals-after-down-year-fda-signs-bounty-new-medicines [2]https://www.prnewswire.com/news-releases/fda-approves-first-oral-treatment-for-postpartum-depression-301894037.html [3]https://www....